Gut Molecule Helps Mice Recover From Intestinal Damage

Rutgers researchers found a bacteria-produced compound that restored intestinal stem cell regeneration in mice and fruit flies.

Updated on Nov. 22, 2026 in Science

Clear unlabeled glass vials of pale amber liquid in a rack on a steel laboratory bench, with a pipette resting across them in bright daylight.
Rutgers researchers reported in Science Advances that a gut-bacteria molecule, N-MNA, helped mice with severely damaged colons recover from what would otherwise have been fatal injury. AI Illustration. Upload story photo >

Live Poll

Do you trust scientists to deliver effective new treatments for digestive disease?

Rutgers researchers reported in Science Advances on November 6, 2026, that a molecule produced by gut bacteria, N-MNA, helped mice with severely damaged colons recover from what would otherwise have been fatal injury. The compound has not yet been tested as a treatment in humans.

Why it matters

NAD cannot enter cells directly, so the finding points to a precursor molecule cells can absorb and convert into NAD, a possible route to repairing damaged intestinal tissue. Lower N-MNA levels in stool samples from patients with inflammatory bowel disease in New Jersey research may eventually help identify patients who could benefit from certain probiotics.

The study compared mice and fruit flies treated with N-MNA against untreated controls, showing weight loss falling from 20% to 5% and fruit fly survival rising from 43% to 78%. Whether these animal results will hold in people has not been determined, as the compound has not yet been tested in humans.

The players

Rutgers New Jersey Medical School

A medical school within Rutgers University, one of New Jersey's largest public research universities, and an institution of a senior study author.

Rutgers Robert Wood Johnson Medical School

The medical school of Rutgers University in New Brunswick, New Jersey, and an institution of a senior study author.

Rutgers University-Newark

The Newark campus of Rutgers University, a public research university in New Jersey, and the institution of the study's first author.

The details

N-MNA is converted back into NAD, a coenzyme that cells cannot absorb directly, and it closely resembles a molecule human cells produce when disposing of excess NAD building blocks. The research is supported by a five-year, $3.6 million National Institutes of Health grant.

Timeline

  1. November 6, 2026: Science Advances published the N-MNA study.

  2. November 22, 2026: Scitechdaily published an article on the study.

Life Sciences Context

The findings extend a growing body of research linking gut bacteria metabolites to intestinal repair, shifting attention from broad microbiome composition toward individual molecules that cells can use directly. The work builds on earlier observations that inflammatory bowel disease is associated with altered gut bacteria, though the causal mechanism is still being mapped.

For now, the finding does not change treatment for inflammatory bowel disease, since the compound has only been tested in animals and fruit flies. Patients should continue to follow their physicians' guidance rather than seek unproven supplements based on this research.

The takeaway

The study points to a specific molecule that may support intestinal repair, but human testing is needed before it could become a treatment. Readers should treat the result as early-stage laboratory evidence.

Further reading

For more on related research, explore Life Sciences coverage on Wisevoter.

Source note: This article includes information reported by SciTechDaily.

Live Poll

Do you trust scientists to deliver effective new treatments for digestive disease?